시장보고서
상품코드
1285997

세계의 림프부종 치료 시장(2023-2030년) : 최종사용자, 제품 유형, 증상 유형, 치료 유형별 규모, 점유율, 성장 분석, 예측

Global Lymphedema Treatment Market Size, Share, Growth Analysis, By End-User, By Product, By Condition Type, By Treatment Type - Industry Forecast 2023-2030

발행일: | 리서치사: SkyQuest | 페이지 정보: 영문 165 Pages | 배송안내 : 3-5일 (영업일 기준)

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

림프부종 치료 시장 규모는 2021년에 7억 8,653만 달러, 2022년에 8억 6,014만 달러를 나타내고, 2023년에서 2030년까지 예측기간 중 9.5%의 CAGR로 성장하여 2030년에는 17억 3,536만 달러 규모로 성장할 것으로 예측됩니다.

유방암 발생률 상승, 림프부종 유병률 상승, 시장 진출 기업에 의한 다수의 신제품 도입, 기술 진보 결과로서 효율적인 제품에 대한 요구 상승 등이 림프부종 치료 시장 성장을 촉진하는 주요 요인이 되고 있습니다.

세계의 림프부종 치료 시장을 조사했으며, 시장 개요, 시장에 대한 각종 영향요인 분석, 기술·혁신 동향, 시장 규모 추정과 예측, 각종 부문·지역별 내역, 경쟁 상황, 주요 기업 개요 등을 정리했습니다.

목차

주요 요약

상부 시장 분석

  • 시장 개요
  • 시장 규모
  • 시장 역학
  • 성장 촉진요인
  • 기회
  • 성장 억제요인
  • 과제
  • 주요 시장 인사이트
  • 기술 분석
  • 가격 분석
  • 공급망 분석
  • 밸류체인 분석
  • 시장 생태계
  • IP 분석
  • 무역 분석
  • 스타트업 분석
  • 원재료 분석
  • 혁신 매트릭스
  • 파이프라인 제품 분석
  • 거시경제 지표
  • 주요 투자 분석
  • 핵심성공요인
  • 경쟁 정도
  • 시장 역학과 전망
  • 시장 역학
  • 성장 촉진요인
  • 기회
  • 성장 억제요인
  • 과제
  • 규제 상황
  • Porters 분석
  • 향후 디스럽션에 관한 Skyquest의 특별한 인사이트
  • 세계의 림프부종 치료 시장 : 최종사용자별
  • 시장 개요
  • 병원
  • 외래 수술 센터
  • 전문 클리닉
  • 기타
  • 세계의 림프부종 치료 시장 : 제품별
  • 시장 개요
  • 압박 붕대
  • 압박 스타킹
  • 공압식 압박 디바이스
  • 기타
  • 세계의 림프부종 치료 시장 : 증상 유형별
  • 시장 개요
  • 심혈관질환
  • 염증성 질환
  • 기타
  • 세계의 림프부종 치료 시장 : 치료 유형별
  • 시장 개요
  • 압박요법
  • 수술
  • 약물요법
  • 레이저 치료
  • 기타
  • 세계의 림프부종 치료 시장 : 지역별
  • 시장 개요
  • 북미
  • 미국
  • 캐나다
  • 유럽
  • 독일
  • 스페인
  • 프랑스
  • 영국
  • 기타 유럽
  • 아시아태평양
  • 중국
  • 인도
  • 일본
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 브라질
  • 기타 라틴아메리카
  • 중동 및 아프리카
  • GCC 국가
  • 남아프리카공화국
  • 기타 중동 및 아프리카
  • 경쟁 상황
  • 주요 5개사 비교
  • 주요 기업의 포지셔닝
  • 주요 기업의 채용 전략
  • 주요 성공 전략
  • 시장의 최근 활동
  • 주요 기업의 시장 점유율
  • 주요 기업 개요
  • Bio Compression Systems
  • Tactile Medical
  • Medi
  • Lympha Press
  • Sigvaris
  • BSN Medical
  • L&R USA Inc.
  • Devon Medical Products
  • 3M Health Care
  • JOBST USA
  • Thuasne
  • Wright Therapy Products
  • BioHorizons IPH, Inc.
  • Haddenham Healthcare
  • ArjoHuntleigh
  • Paul Hartmann
  • Bioventus
  • Baxter International Inc.
  • CircAid Medical Products, Inc.
  • Essity Aktiebolag
KSM 23.06.15

Lymphedema Treatment Market size was valued at USD 786.53 million in 2021 and is poised to grow from USD 860.14 million in 2022 to USD 1735.36 million by 2030, growing at a CAGR of 9.5% in the forecast period (2023-2030).

A condition known as lymphedema is characterised by abnormal swelling of the body brought on by lymphocytosis as a result of lymphatic system failure. The lower extremity is affected 90% of the time, the upper extremity 10%, and the genitalia 1%. The most common cause of lymphedema (filariasis) is an infection brought on by the parasite Wuchereria bancrofti. Lymphedema is among the most dreaded and unlucky side effects of breast cancer treatment. According to a National Centre for Biotechnology Information (NCBI) research, 40 percent of breast cancer patients experienced lymphedema. The primary factors driving the growth of the lymphedema treatment market are the rising incidence of breast cancer, the rising prevalence of lymphedema, the introduction of several new products by prominent market participants, and the rising need for efficient products as a consequence of technological advancements.

The lymph node draining condition known as lymphedema can appear in cancer patients before or after treatment, according to the US Department of Health and Human Services. For instance, it has been noted that it may occur immediately or up to 30 years after breast cancer treatment. Additionally, 80% of patients start showing symptoms 3 years after surgery, with the remaining 20% developing edoema at a rate of 1% every year. Additionally, after the treatment of gynecologic cancer, a sizeable patient population, primarily women, develops lower-limb lymphedema, with vulvar cancer survivors having the highest frequency (37%) and ovarian cancer survivors having the lowest prevalence (7%). Additionally, the incidence of arm lymphedema varied from 8% to 56% two years after surgery. According to the Alliance Z 1071 longitudinal substudy of the American College of Surgeons Oncology Group (ACOSOG), participants in breast cancer trials report a 3-year cumulative incidence of arm edoema and arm heaviness. Cutting edge and very effective cancer treatment options aid in lowering the risk of lymphedema. The major players in the market for cancer therapeutics are working very hard to introduce innovative products as a result.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Lymphedema Treatment Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Segments covered in this report:

Based on end-user, the market is segmented into hospitals, ambulatory surgical centers, specialty clinics, and others. Based on product, the market is segmented into compression bandages, compression stockings, pneumatic compression devices, others. Based on affected area, the market is segmented into Genital, Lower Extremity, Upper Extremity and Others. Based on age group, the market is segmented into adult and geriatric. Based on route of administration, the market is segmented into Oral, Injectable and Others. Based on type, the market is segmented into primary and secondary lymphedema. Based on condition type, the market is segmented into cancer, cardiovascular diseases, inflammatory diseases, and others. Based on treatment type, the market is segmented into Compression Therapy, Surgery, Drug Therapy, Laser Therapy, and Others. Based on region, the global market is segmented into North America, Europe, Asia-Pacific, South America, and MEA.

Driver

As cases of breast cancer and lymphedema rise, it is projected that the market for lymphedema treatments would expand. The likelihood of developing cancer is predicted to rise, creating tremendous opportunity for market expansion. Increasing health spending and growing investments in drug discovery research and development have increased the demand for healthcare facilities. The development of novel lymphedema treatment options is also projected to support market expansion throughout the forecasted period.

The market expansion in the upcoming years is projected to be accelerated by technological developments in lymphedema treatment methods. Additionally, the rise of the market is undoubtedly facilitated by the government's favourable programmes and the reimbursement requirements.

Restraint

Despite advances in technology, there is still no permanent treatment for lymphedema, which is anticipated to limit market growth.

The high cost of procedures and treatments is anticipated to restrict market growth.

Market Trends

As more people experience the ailment, the market for lymphedema treatments is anticipated to grow. Additionally, innovative and cutting-edge treatments are being developed at an exponential rate to lower risk throughout treatment as the disease develops further. Increasing healthcare spending is also predicted to spur industry growth and an increase in healthcare innovation. Additionally, pharmaceutical companies are encouraging worldwide business globalisation by introducing cutting-edge medical equipment.

Table of Contents

Executive Summary

  • Market Overview
  • Wheel of Fortune
  • Research Methodology
  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations

Parent Market Analysis

  • Market Overview
  • Market Size
  • Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
  • Key Market Insights
  • Technology Analysis
  • Pricing Analysis
  • Supply Chain Analysis
  • Value Chain Analysis
  • Ecosystem of the Market
  • IP Analysis
  • Trade Analysis
  • Startup Analysis
  • Raw Material Analysis
  • Innovation Matrix
  • Pipeline Product Analysis
  • Macroeconomic Indicators
  • Top Investment Analysis
  • Key Success Factor
  • Degree of Competition
  • Market Dynamics & Outlook
  • Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
  • Regulatory Landscape
  • Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers
  • Skyquest Special Insights on Future Disruptions
  • Political Impact
  • Economic Impact
  • Social Impact
  • Technical Impact
  • Environmental Impact
  • Legal Impact
  • Global Lymphedema Treatment Market by End-User
  • Market Overview
  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics
  • Others
  • Global Lymphedema Treatment Market by Product
  • Market Overview
  • Compression Bandages
  • Compression Stockings
  • Pneumatic Compression Devices
  • Others
  • Global Lymphedema Treatment Market by Condition Type
  • Market Overview
  • Cancer
  • Cardiovascular Diseases
  • Inflammatory Diseases
  • Others
  • Global Lymphedema Treatment Market by Treatment Type
  • Market Overview
  • Compression Therapy
  • Surgery
  • Drug Therapy
  • Laser Therapy
  • Others
  • Global Lymphedema Treatment Market Size by Region
  • Market Overview
  • North America
  • USA
  • Canada
  • Europe
  • Germany
  • Spain
  • France
  • UK
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
  • Latin America
  • Brazil
  • Rest of Latin America
  • Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA
  • Competitive Landscape
  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2021
  • Strategies Adopted by Key Market Players
  • Top Winning Strategies
  • By Development
  • By Company
  • By Year
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2021
  • Key Company Profiles
  • Bio Compression Systems
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • Tactile Medical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • Medi
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • Lympha Press
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • Sigvaris
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • BSN Medical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • L&R USA Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • Devon Medical Products
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • 3M Health Care
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • JOBST USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • Thuasne
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • Wright Therapy Products
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • BioHorizons IPH, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • Haddenham Healthcare
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • ArjoHuntleigh
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • Paul Hartmann
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • Bioventus
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • Baxter International Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • CircAid Medical Products, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • Essity Aktiebolag
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제